Tofacitinib Helps in Ulcerative Colitis (CME/CE)
(MedPage Today) — The oral JAK inhibitor tofacitinib, currently under FDA review for treating rheumatoid arthritis, also showed promise for ulcerative colitis in a randomized trial.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com